These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18702538)

  • 1. Proteomic analysis of testis biopsies in men treated with injectable testosterone undecanoate alone or in combination with oral levonorgestrel as potential male contraceptive.
    Cui Y; Zhu H; Zhu Y; Guo X; Huo R; Wang X; Tong J; Qian L; Zhou Z; Jia Y; Lue YH; Hikim AS; Wang C; Swerdloff RS; Sha J
    J Proteome Res; 2008 Sep; 7(9):3984-93. PubMed ID: 18702538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal contraception in Chinese men: variations in suppression of spermatogenesis with injectable testosterone undecanoate and levonorgestrel implants.
    Liu ST; Gui YL; Lin CH; He CH
    Asian J Androl; 2004 Mar; 6(1):41-6. PubMed ID: 15064833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men.
    Lue Y; Wang C; Cui Y; Wang X; Sha J; Zhou Z; Xu J; Wang C; Hikim AP; Swerdloff RS
    Biol Reprod; 2009 Mar; 80(3):484-92. PubMed ID: 19074003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
    Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
    J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
    Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
    J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats.
    Misro MM; Chaki SP; Kaushik MC; Nandan D
    Contraception; 2009 Jun; 79(6):488-97. PubMed ID: 19442786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of testis biopsies in men treated with transient scrotal hyperthermia reveals the potential targets for contraceptive development.
    Zhu H; Cui Y; Xie J; Chen L; Chen X; Guo X; Zhu Y; Wang X; Tong J; Zhou Z; Jia Y; Lue YH; Hikim AS; Wang C; Swerdloff RS; Sha J
    Proteomics; 2010 Oct; 10(19):3480-93. PubMed ID: 20815088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in chinese men.
    Gui YL; He CH; Amory JK; Bremner WJ; Zheng EX; Yang J; Yang PJ; Gao ES
    J Androl; 2004; 25(5):720-7. PubMed ID: 15292101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis.
    Wang C; Cui YG; Wang XH; Jia Y; Sinha Hikim A; Lue YH; Tong JS; Qian LX; Sha JH; Zhou ZM; Hull L; Leung A; Swerdloff RS
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3292-304. PubMed ID: 17504903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.
    Kamischke A; Plöger D; Venherm S; von Eckardstein S; von Eckardstein A; Nieschlag E
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):43-52. PubMed ID: 10931079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrity of the blood-testis barrier in healthy men after suppression of spermatogenesis with testosterone and levonorgestrel.
    Ilani N; Armanious N; Lue YH; Swerdloff RS; Baravarian S; Adler A; Tsang C; Jia Y; Cui YG; Wang XH; Zhou ZM; Sha JH; Wang C
    Hum Reprod; 2012 Dec; 27(12):3403-11. PubMed ID: 23019303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist.
    Matthiesson KL; Amory JK; Berger R; Ugoni A; McLachlan RI; Bremner WJ
    J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
    Kamischke A; Venherm S; Plöger D; von Eckardstein S; Nieschlag E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men.
    Yang ZJ; Ye WS; Cui GH; Guo Y; Xue SP
    Contraception; 2004 Sep; 70(3):203-11. PubMed ID: 15325889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role of progestin and the progesterone receptor in the suppression of spermatogenesis in rodents.
    Lue Y; Wang C; Lydon JP; Leung A; Li J; Swerdloff RS
    Andrology; 2013 Mar; 1(2):308-17. PubMed ID: 23408752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations.
    Kamischke A; Heuermann T; Krüger K; von Eckardstein S; Schellschmidt I; Rübig A; Nieschlag E
    J Clin Endocrinol Metab; 2002 Feb; 87(2):530-9. PubMed ID: 11836281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
    Herbst KL; Anawalt BD; Amory JK; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1167-73. PubMed ID: 12629101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men.
    Qoubaitary A; Meriggiola C; Ng CM; Lumbreras L; Cerpolini S; Pelusi G; Christensen PD; Hull L; Swerdloff RS; Wang C
    J Androl; 2006; 27(6):853-67. PubMed ID: 16837736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete sperm suppression induced by dienogest plus testosterone undecanoate is associated with down-regulation in the expression of upstream steroidogenic enzyme genes in rat testis.
    Meena R; Misro MM; Ghosh D; Nandan D
    Contraception; 2012 Aug; 86(2):163-71. PubMed ID: 22264663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.